On 17 September 2015, the Academy of Medical Sciences, in partnership with the Association of the British Pharmaceutical Industry, held a FORUM workshop on 'Real world evidence' to explore the acceptability of real world evidence.Launched
Real world data
The Academy's FORUM hosted a scoping roundtable on 24 January 2018 to examine the progress in the use of real world data and evidence since the 2015 workshop.
The roundtable brought together senior representatives from across academia, industry, the NHS, regulatory agencies and funders to examine the environment for the use of real world evidence (RWE) in health technology development, assessment and evaluation. This roundtable forms part of the follow-up work to the 2015 workshop on real world evidence, which focused on regulatory acceptability of RWE, and examined how the landscape has changed since then.
The roundtable was chaired by Sir Alasdair Breckenridge CBE FRSE FMedSci, Former Chair of the Medicines and Healthcare products Regulatory Agency and Professor Andrew Morris CBE FRSE FMedSci, Director of Health Data Research UK and Professor of Diabetic Medicine, University of Edinburgh, and took place on 24 January 2018 at the Academy’s offices at 41 Portland Place, London, W1B 1QH.
This meeting was by invitation only and the summary meeting report has now been published and can be found on the right hand side of this page. For further details please contact email@example.com.
Interim Head of Policy
Tel: –View staff bio